Research & Literature

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction.

Yeh RW, Kereiakes DJ, Steg PG, et al.

Journal of the American College of Cardiology 2015; (65(20)):2211-21.

Clinical picture and risk prediction of short-term mortality in cardiogenic shock.

Harjola VP, Lassus J, Sionis A, et al.

European journal of heart failure 2015; (17(5)):501-9 doi:10.1002/ejhf.260.

Randomized trial of primary PCI with or without routine manual thrombectomy.

Jolly SS, Cairns JA, Yusuf S, et al.

The New England journal of medicine 2015; (372(15)):1389-98 doi:10.1056/NEJMoa1415098.

Factors Affecting Bleeding and Stent Thrombosis in Clinical Trials Comparing Bivalirudin With Heparin During Percutaneous Coronary Intervention.

Bittl JA, He Y, Lang CD, Dangas GD

Circulation. Cardiovascular interventions 2015; (8(12)):e002789.

Risk stratification in non-ST elevation acute coronary syndromes: Risk scores, biomarkers and clinical judgment.

Corcoran D, Grant P, Berry C

International journal of cardiology. Heart & vasculature 2015; (8()):131-137 doi:10.1016/j.ijcha.2015.06.009.

Anticoagulation in coronary intervention.

Zeymer U, Rao SV, Montalescot G

European heart journal 2016; (37(45)):3376-3385 doi:10.1093/eurheartj/ehw061.

A review of guidelines for cardiac rehabilitation exercise programmes: Is there an international consensus?

Price KJ, Gordon BA, Bird SR, Benson AC

European journal of preventive cardiology 2016; (23(16)):1715-1733 doi:10.1177/2047487316657669.

Cardiac Rehabilitation: Improving Function and Reducing Risk.

Servey JT, Stephens M

American family physician 2016; (94(1)):37-43.

Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.

Sim DS, Jeong MH, Ahn Y, et al.

Circulation. Cardiovascular interventions 2016; (9(9)).

Myocardial Infarction Type 2 and Myocardial Injury.

Sandoval Y, Thygesen K

Clinical chemistry 2017; (63(1)):101-107 doi:10.1373/clinchem.2016.255521.

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator-The PROLONG Study.

Duncker D, König T, Hohmann S, et al.

Journal of the American Heart Association 2017; (6(1)) doi:10.1161/JAHA.116.004512.

Medical Therapy for Secondary Prevention and Long-Term Outcome in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.

Lindahl B, Baron T, Erlinge D, et al.

Circulation 2017; (135(16)):1481-1489 doi:10.1161/CIRCULATIONAHA.116.026336.

High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification.

Kozinski M, Krintus M, Kubica J, Sypniewska G

Critical reviews in clinical laboratory sciences 2017; (54(3)):143-172 doi:10.1080/10408363.2017.1285268.

Rehospitalizations Following Primary Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction: Results From a Multi-Center Randomized Trial.

Spitzer E, Frei M, Zaugg S, et al.

Journal of the American Heart Association 2017; (6(8)) doi:10.1161/JAHA.117.005926.

Is Atherothromboaspiration a Possible Solution for the Prevention of No-Reflow Phenomenon in Acute Coronary Syndromes? Single Centre Experience and Review of the Literature.

Manolis AS

Current vascular pharmacology 2019; (17(2)):164-179 doi:10.2174/1570161116666180101150956.

Change in Left Ventricular Ejection Fraction Following First Myocardial Infarction and Outcome.

Chew DS, Heikki H, Schmidt G, et al.

JACC. Clinical electrophysiology 2018; (4(5)):672-682 doi:10.1016/j.jacep.2017.12.015.

Use of objective evidence of myocardial ischemia to facilitate the diagnostic and prognostic distinction between type 2 myocardial infarction and myocardial injury.

Sandoval Y, Smith SW, Sexter A, et al.

European heart journal. Acute cardiovascular care 2020; (9(1)):62-69 doi:10.1177/2048872618787796.

Platelet to Lymphocyte Ratio on Admission and Prognosis in Patients with Acute Cardiogenic Pulmonary Edema.

Demir M, Duyuler PT, Guray U, Celik MC

The Journal of emergency medicine 2018; (55(4)):465-471 doi:10.1016/j.jemermed.2018.06.021.

Effect of Guideline-Based Therapy on Left Ventricular Systolic Function Recovery After ST-Segment Elevation Myocardial Infarction.

Abou R, Leung M, Goedemans L, et al.

The American journal of cardiology 2018; (122(10)):1591-1597 doi:10.1016/j.amjcard.2018.07.035.

Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction.

Rodríguez-Zanella H, Muraru D, Secco E, et al.

JACC. Cardiovascular imaging 2019; (12(10)):1917-1926 doi:10.1016/j.jcmg.2018.07.011.

[4th universal definition of myocardial infarction 2018 : What is new?]

Brinkmann C, Schofer J

Herz 2018; (43(8)):681-688 doi:10.1007/s00059-018-4763-6.

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.

Schwartz GG, Steg PG, Szarek M, et al.

The New England journal of medicine 2018; (379(22)):2097-2107 doi:10.1056/NEJMoa1801174.

Early Versus Standard Care Invasive Examination and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Kofoed KF, Kelbæk H, Hansen PR, et al.

Circulation 2018; (138(24)):2741-2750 doi:10.1161/CIRCULATIONAHA.118.037152.

Post-myocardial Infarction (MI) Care: Medication Adherence for Secondary Prevention After MI in a Large Real-world Population.

Huber CA, Meyer MR, Steffel J, et al.

Clinical therapeutics 2019; (41(1)):107-117 doi:10.1016/j.clinthera.2018.11.012.

[Acute coronary syndrome with ST-elevation].

Haude M, Rupprecht HJ, Schuster S, Uebis R

Herz 2019; (44(1)):16-21 doi:10.1007/s00059-018-4775-2.

Type 2 Myocardial Infarction: JACC Review Topic of the Week.

Sandoval Y, Jaffe AS

Journal of the American College of Cardiology 2019; (73(14)):1846-1860 doi:10.1016/j.jacc.2019.02.018.

Evaluation of acute myocardial infarction patients with mid-range ejection fraction after emergency percutaneous coronary intervention.

Jiang Y, Hu S, Cao M, et al.

Postgraduate medical journal 2019; (95(1125)):355-360 doi:10.1136/postgradmedj-2018-136334.

Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.

Guedeney P, Giustino G, Sorrentino S, et al.

European heart journal 2022; (43(7)):e17-e25 doi:10.1093/eurheartj/ehz430.

Vertebral Artery Dissection and Takotsubo Syndrome Associated with Marijuana Use.

Sanchez-Nadales A, Anampa-Guzmán A

Cureus 2019; (11(5)):e4785 doi:10.7759/cureus.4785.

Early Phase II Comprehensive Cardiac Rehabilitation after Acute Myocardial Infarction.

Tsai YJ, Huang WC, Weng TP, Lin KL

Acta Cardiologica Sinica 2019; (35(4)):425-429 doi:10.6515/ACS.201907_35(4).20190330A.

Assessment and Treatment of Patients With Type 2 Myocardial Infarction and Acute Nonischemic Myocardial Injury.

DeFilippis AP, Chapman AR, Mills NL, et al.

Circulation 2019; (140(20)):1661-1678 doi:10.1161/CIRCULATIONAHA.119.040631.

Five-year outcomes following timely primary percutaneous intervention, late primary percutaneous intervention, or a pharmaco-invasive strategy in ST-segment elevation myocardial infarction: the FAST-MI programme.

Danchin N, Popovic B, Puymirat E, et al.

European heart journal 2020; (41(7)):858-866 doi:10.1093/eurheartj/ehz665.

Type 2 myocardial infarction in general medical wards: Clinical features, treatment, and prognosis in comparison with type 1 myocardial infarction.

Furie N, Israel A, Gilad L, et al.

Medicine 2019; (98(41)):e17404 doi:10.1097/MD.0000000000017404.

[Severe bleeding with antiplatelet therapy: What to do?]

Cayla G, Cornillet L, Ledermann B, et al.

Presse medicale (Paris, France : 1983) 2019; (48(12)):1416-1421 doi:10.1016/j.lpm.2019.08.017.

Myocardial infarction with non-obstructive coronary arteries: A comprehensive review and future research directions.

Vidal-Perez R, Abou Jokh Casas C, Agra-Bermejo RM, et al.

World journal of cardiology 2019; (11(12)):305-315 doi:10.4330/wjc.v11.i12.305.

Application of the 2019 ESC/EAS dyslipidaemia guidelines to nationwide data of patients with a recent myocardial infarction: a simulation study.

Allahyari A, Jernberg T, Hagström E, et al.

European heart journal 2020; (41(40)):3900-3909 doi:10.1093/eurheartj/ehaa034.

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease.

Paolisso P, Bergamaschi L, Saturi G, et al.

Frontiers in pharmacology 2019; (10()):1606 doi:10.3389/fphar.2019.01606.

Sacubitril/Valsartan Improves Left Ventricular Ejection Fraction and Reverses Cardiac Remodeling in Taiwanese Patients with Heart Failure and Reduced Ejection Fraction.

Liu LW, Wu PC, Chiu MY, et al.

Acta Cardiologica Sinica 2020; (36(2)):125-132 doi:10.6515/ACS.202003_36(2).20190812A.

Meta-analysis Comparing Outcomes of Type 2 Myocardial Infarction and Type 1 Myocardial Infarction With a Focus on Dual Antiplatelet Therapy.

Reid C, Alturki A, Yan A, et al.

CJC open 2020; (2(3)):118-128 doi:10.1016/j.cjco.2020.02.005.

Effect of Medication Adherence and Early Follow-Up on Unplanned Readmission Post-Myocardial Infarction: Quality Improvement in a Safety Net Hospital.

Ashraf H, Warren E, Latner JP, et al.

Critical pathways in cardiology 2021; (20(2)):71-74 doi:10.1097/HPC.0000000000000231.

Troponin-Positive Non-Obstructive Coronary Arteries and Myocardial Infarction with Non-Obstructive Coronary Arteries: Definition, Etiologies, and Role of CT and MR Imaging.

Yoo SM, Jang S, Kim JA, Chun EJ

Korean journal of radiology 2020; (21(12)):1305-1316 doi:10.3348/kjr.2020.0064.

Antithrombotic PreTreatment and Invasive Strategies in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome.

Camaro C, Damman P

Journal of clinical medicine 2020; (9(8)) doi:10.3390/jcm9082578.

Dual Antiplatelet Therapy After Percutaneous Coronary Intervention and Drug-Eluting Stents: A Systematic Review and Network Meta-Analysis.

Khan SU, Singh M, Valavoor S, et al.

Circulation 2020; (142(15)):1425-1436 doi:10.1161/CIRCULATIONAHA.120.046308.

High-Sensitivity Troponin I Assay for Differential Diagnosis of New-Onset Myocardial Infarction in Patients with Acute Decompensated Heart Failure.

Han JH, Hwang SO, Cha KC, et al.

Yonsei medical journal 2021; (62(2)):129-136 doi:10.3349/ymj.2021.62.2.129.

The Optimal Timing of Primary Prevention Implantable Cardioverter-Defibrillator Referral in the Rapidly Changing Medical Landscape.

Wong JA, Roberts JD, Healey JS

The Canadian journal of cardiology 2021; (37(4)):644-654 doi:10.1016/j.cjca.2021.01.024.

Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association.

Bozkurt B, Coats AJS, Tsutsui H, et al.

European journal of heart failure 2021; (23(3)):352-380 doi:10.1002/ejhf.2115.

Early Comprehensive Cardiovascular Magnetic Resonance Imaging in Patients With Myocardial Infarction With Nonobstructive Coronary Arteries.

Sörensson P, Ekenbäck C, Lundin M, et al.

JACC. Cardiovascular imaging 2021; (14(9)):1774-1783 doi:10.1016/j.jcmg.2021.02.021.

[Smoking cessation - achievable and effective].

Andreas S, Pankow W

Deutsche medizinische Wochenschrift (1946) 2021; (146(11)):748-751 doi:10.1055/a-1259-8353.

Cardiac arrests in general practice clinics or witnessed by emergency medical services: a 20-year retrospective study.

Haskins B, Nehme Z, Cameron PA, Smith K

The Medical journal of Australia 2021; (215(5)):222-227 doi:10.5694/mja2.51139.

Predictors of the Use of Mineralocorticoid Receptor Antagonists in Patients With Left Ventricular Dysfunction Post-ST-Segment-Elevation Myocardial Infarction.

Wong EC, Fordyce CB, Wong G, et al.

Journal of the American Heart Association 2021; (10(14)):e019167 doi:10.1161/JAHA.120.019167.

Effect of early home-based exercise for cardiac rehabilitation on the prognosis of patients with acute myocardial infarction after percutaneous coronary intervention.

Yu H, Yang H

American journal of translational research 2021; (13(7)):7839-7847.

Importance of Risk Assessment in Timing of Invasive Coronary Evaluation and Treatment of Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome: Insights From the VERDICT Trial.

Butt JH, Kofoed KF, Kelbæk H, et al.

Journal of the American Heart Association 2021; (10(19)):e022333 doi:10.1161/JAHA.121.022333.

Sex Differences in Symptom Phenotypes Among Older Patients with Acute Myocardial Infarction.

Brush JE, Hajduk AM, Greene EJ, et al.

The American journal of medicine 2022; (135(3)):342-349 doi:10.1016/j.amjmed.2021.09.022.

Long-Term Pharmacological Management of Reduced Ejection Fraction Following Acute Myocardial Infarction: Current Status and Future Prospects.

Abel AAI, Clark AL

International journal of general medicine 2021; (14()):7797-7805 doi:10.2147/IJGM.S294896.

Prediction of early death after myocardial infarction in patients with reduced left ventricular ejection fraction. The search for new indications for cardioverter-defibrillator implantation (ICD).

Pres D, Tajstra M, Mitkowski P, et al.

Kardiologia polska 2021; (79(12)):1343-1352 doi:10.33963/KP.a2021.0177.

Improving smoking cessation after myocardial infarction by systematically implementing evidence-based treatment methods.

Leosdottir M, Wärjerstam S, Michelsen HÖ, et al.

Scientific reports 2022; (12(1)):642 doi:10.1038/s41598-021-04634-5.

Diagnostic Value of Cardiac Magnetic Resonance Imaging and Intracoronary Optical Coherence Tomography in Patients With a Working Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries - A Systematic Review and Meta-analysis.

Machanahalli Balakrishna A, Ismayl M, Thandra A, et al.

Current problems in cardiology 2023; (48(6)):101126 doi:10.1016/j.cpcardiol.2022.101126.

Killip-Kimball classification in octogenarians with acute coronary syndrome: An 11-year experience.

Ramonfaur D, Hinojosa-González DE, Paredes-Vázquez JG

Archivos de cardiologia de Mexico 2022; (92(4)):425-430 doi:10.24875/ACM.21000046.

Stress-Induced Cardiomyopathy Raising Concern for Myocardial Ischemia.

Singh A, Everest S, Nguyen L, et al.

Cureus 2022; (14(2)):e22091 doi:10.7759/cureus.22091.

Analytical Considerations in Deriving 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin Assays: Educational Recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers.

Aakre KM, Saenger AK, Body R, et al.

Clinical chemistry 2022; (68(8)):1022-1030 doi:10.1093/clinchem/hvac092.

Role of Implantable Cardioverter Defibrillator in Heart Failure With Contemporary Medical Therapy.

Butler J, Talha KM, Aktas MK, et al.

Circulation. Heart failure 2022; (15(8)):e009634 doi:10.1161/CIRCHEARTFAILURE.122.009634.

Assessment of Oxygen Supply-Demand Imbalance and Outcomes Among Patients With Type 2 Myocardial Infarction: A Secondary Analysis of the High-STEACS Cluster Randomized Clinical Trial.

Bularga A, Taggart C, Mendusic F, et al.

JAMA network open 2022; (5(7)):e2220162 doi:10.1001/jamanetworkopen.2022.20162.

MINOCA: One Size Fits All? Probably Not-A Review of Etiology, Investigation, and Treatment.

Herling de Oliveira LL, Correia VM, Nicz PFG, et al.

Journal of clinical medicine 2022; (11(19)) doi:10.3390/jcm11195497.

Effects of routine early treatment with PCSK9 inhibitors in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a randomised, double-blind, sham-controlled trial.

Mehta SR, Pare G, Lonn EM, et al.

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(11)):e888-e896 doi:10.4244/EIJ-D-22-00735.

The First National Program of Remote Cardiac Rehabilitation in Israel-Goal Achievements, Adherence, and Responsiveness in Older Adult Patients: Retrospective Analysis.

Nabutovsky I, Breitner D, Heller A, et al.

JMIR cardio 2022; (6(2)):e36947 doi:10.2196/36947.

Myocardial infarction with non-obstructive coronary arteries (MINOCA).

Yildiz M, Ashokprabhu N, Shewale A, et al.

Frontiers in cardiovascular medicine 2022; (9()):1032436 doi:10.3389/fcvm.2022.1032436.

Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials.

Costa F, Montalto C, Branca M, et al.

European heart journal 2023; (44(11)):954-968 doi:10.1093/eurheartj/ehac706.

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction ("Jena auf Ziel").

Makhmudova U, Samadifar B, Maloku A, et al.

Clinical research in cardiology : official journal of the German Cardiac Society 2023; (112(9)):1212-1219 doi:10.1007/s00392-022-02147-3.

Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis.

Dibben GO, Faulkner J, Oldridge N, et al.

European heart journal 2023; (44(6)):452-469 doi:10.1093/eurheartj/ehac747.

Repetitive catamenial myocardial infarction due to coronary artery spasm: a case report.

Talmor N, Gurin M, Smilowitz N, et al.

European heart journal. Case reports 2023; (7(2)):ytad019 doi:10.1093/ehjcr/ytad019.

Clinical Decision Pathway for the Use of Fondaparinux in the Management of Acute Coronary Syndrome (ACS) in Hospitals with and Without Catheter Laboratories: An Expert Opinion from India.

Ray S, Shivdasani B, Mohan JC, et al.

Cardiology and therapy 2023; (12(2)):261-274 doi:10.1007/s40119-023-00312-x.

Adherence to guideline-directed medical therapy and 3-year clinical outcome following acute myocardial infarction.

Lee SH, Hyun D, Choi J, et al.

European heart journal open 2023; (3(2)):oead029 doi:10.1093/ehjopen/oead029.

Temporal trends in cardiovascular risk factors, lifestyle and secondary preventive medication for patients with myocardial infarction attending cardiac rehabilitation in Sweden 2006-2019: a registry-based cohort study.

Leosdottir M, Hagstrom E, Hadziosmanovic N, et al.

BMJ open 2023; (13(5)):e069770 doi:10.1136/bmjopen-2022-069770.

European practice patterns for antiplatelet management in NSTE-ACS patients: Results from the REal-world ADoption survey focus on Acute antiPlatelet Treatment (READAPT) survey.

Angiolillo DJ, Erlinge D, Ferreiro JL, et al.

International journal of cardiology 2023; (386()):8-16 doi:10.1016/j.ijcard.2023.05.025.

Sudden Cardiac Death in Ischaemic Cardiomyopathy and the Primary Prevention ICD: Time for a More a Personalised Approach?

Ezad SM, Babu G, O'Kane P

Interventional cardiology (London, England) 2023; (18()):e11 doi:10.15420/icr.2022.14.

2023 TAMIS/TSOC/TACVPR Consensus Statement for Patients with Acute Myocardial Infarction Rehabilitation.

Chen KC, Hsu CN, Wu CH, et al.

Acta Cardiologica Sinica 2023; (39(6)):783-806 doi:10.6515/ACS.202311_39(6).20230921A.

[Management of acute coronary syndrome : ESC guidelines 2023].

Buske M, Feistritzer HJ, Jobs A, Thiele H

Herz 2024; (49(1)):5-14 doi:10.1007/s00059-023-05222-1.

Peer-support interventions and related outcomes in patients with myocardial infarction: A systematic review.

Heydari A, Manzari ZS, Mohammadpourhodki R

Heliyon 2024; (10(3)):e25314 doi:10.1016/j.heliyon.2024.e25314.

Clinical Impact of Dyspnea after Ticagrelor Treatment and the Effect of Switching to Clopidogrel in Patients with Myocardial Infarction.

Kim SH, Shin S, Choo EH, et al.

Thrombosis and haemostasis 2024; (124(12)):1152-1161 doi:10.1055/a-2299-4537.

N-terminal pro-B-type natriuretic peptide and pulmonary echography are predictors of acute heart failure needing early mechanical ventilation in acute coronary syndrome.

Cristo-Ropero MJ, Garcia-Rubira JC, Rivera-Rabanal FJ, et al.

Coronary artery disease 2024; (35(7)):556-563 doi:10.1097/MCA.0000000000001396.

Acute myocardial infarction and ischaemic stroke: differences and similarities in reperfusion therapies-a review.

Scheldeman L, Sinnaeve P, Albers GW, et al.

European heart journal 2024; (45(30)):2735-2747 doi:10.1093/eurheartj/ehae371.

Routine beta-blocker therapy after acute coronary syndromes: The end of an era?

Johner N, Gencer B, Roffi M

European journal of clinical investigation 2024; (54(12)):e14309 doi:10.1111/eci.14309.

Core Components of Cardiac Rehabilitation Programs: 2024 Update: A Scientific Statement From the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation.

Brown TM, Pack QR, Aberegg E, et al.

Circulation 2024; (150(18)):e328-e347 doi:10.1161/CIR.0000000000001289.

The in-hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta-analysis.

Di Pietro G, Improta R, Severino P, et al.

ESC heart failure 2025; (12(2)):998-1012 doi:10.1002/ehf2.15082.

Determinants and Outcomes of Invasive Coronary Angiography in Unselected Patients Presenting With Chest Pain to Emergency Departments in Western Australian Teaching Hospitals.

Sanfilippo FM, Murray K, Hillis GS, et al.

Heart, lung & circulation 2023; doi:10.1016/j.hlc.2023.09.011.

The Balancing Act: A Rational Approach to Postintervention Dual Antiplatelet Therapy.

Mehta N, Samat D

The Journal of the Association of Physicians of India 2024; (72(11)):11-13 doi:10.59556/japi.72.0668.

Music therapy combined with motivational interviewing.

Meng DF, Bao J, Cai TZ, et al.

World journal of psychiatry 2024; (14(12)):1886-1891 doi:10.5498/wjp.v14.i12.1886.

Postacute Myocardial Infarction Differences in Physical Activity Behavior, Anxiety, and Depression Levels.

Shajrawi AM, Al-Akash HY, Al-Smadi AM, et al.

SAGE open nursing 2024; (10()):23779608241304478 doi:10.1177/23779608241304478.

Predictors of Left Ventricular Ejection Fraction Decrease in Patients With ST-Segment Elevation Myocardial Infarction.

Pereverzeva KG, Yakushin SS, Tishkina IE, et al.

Kardiologiia 2024; (64(12)):27-34 doi:10.18087/cardio.2024.12.n2729.

Implications of a new clinical classification of acute myocardial infarction.

Boeddinghaus J, Bularga A, Taggart C, et al.

European heart journal. Acute cardiovascular care 2025; (14(3)):131-141 doi:10.1093/ehjacc/zuaf002.

Effects of dapagliflozin on heart rate variability, cardiac function, and short-term prognosis in early-onset post-myocardial infarction heart failure.

Zhou L, Niu M, Chen W, et al.

Frontiers in cardiovascular medicine 2024; (11()):1490316 doi:10.3389/fcvm.2024.1490316.

Understanding Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA): a comprehensive meta-analysis of clinical characteristics, management, and prognosis compared to MI with the Obstructive Coronary Artery (MIOCA).

Khorasani N, Mohammadi Y, Sarpoli M, et al.

BMC cardiovascular disorders 2025; (25(1)):143 doi:10.1186/s12872-025-04504-2.

15-Year trends, predictors, and outcomes of heart failure hospitalization complicating first acute myocardial infarction in the modern percutaneous coronary intervention era.

Rashid M, Abramov D, Naseer MU, et al.

European heart journal open 2025; (5(2)):oeaf013 doi:10.1093/ehjopen/oeaf013.

The Role of Dietary Education in Cardiac Rehabilitation.

Popiolek-Kalisz J, Mazur M, Perone F

Nutrients 2025; (17(6)) doi:10.3390/nu17061082.

Quality Indicators for Diabetes in Adults: A Review of Performance Measures by the American College of Physicians.

Qaseem A, Basch P, Campos K, et al.

Annals of internal medicine 2025; (178(7)):1012-1020 doi:10.7326/ANNALS-24-03770.

Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study.

Rajwani A, Giudicatti L, Telyuk P, et al.

Heart (British Cardiac Society) 2025; (112(2)):95-102 doi:10.1136/heartjnl-2024-325181.

Effects of bisoprolol combined with torasemide on cardiac electrophysiology in patients with acute myocardial infarction and heart failure.

Jing L, Shi Q, Zhao S

Frontiers in physiology 2025; (16()):1629758 doi:10.3389/fphys.2025.1629758.

Rural and Remote Acute STEMI Diagnosis and Management: Current Status and Future Directions.

Gadeley R, Arnold R, Amos D, et al.

Heart, lung & circulation 2025; (34(12)):1332-1343 doi:10.1016/j.hlc.2025.06.1035.

Exercise-based cardiac rehabilitation for coronary heart disease: the CaReMATCH individual participant data meta-analysis.

Stens NA, Buckley BJR, Dibben GO, et al.

European journal of preventive cardiology 2026; (33(6)):841-853 doi:10.1093/eurjpc/zwaf629.

Methodological evaluation and clinical interpretation of hs-cTnI and hs-cTnT variations: a reappraisal.

Clerico A, Zaninotto M, Plebani M

Clinical chemistry and laboratory medicine 2026; (64(3)):566-569 doi:10.1515/cclm-2025-1318.

Beta-Blockers after Myocardial Infarction with Normal Ejection Fraction.

Kristensen AMD, Rossello X, Atar D, et al.

The New England journal of medicine 2026; (394(6)):540-550 doi:10.1056/NEJMoa2512686.

Physical activity and cardiac rehabilitation after myocardial infarction: the risk of obtaining large benefits.

Tonet E, Sabato F, Canovi L, et al.

Panminerva medica 2025; (67(4)):245-253 doi:10.23736/S0031-0808.25.05381-9.

Anxiety disorders following percutaneous coronary intervention for acute myocardial infarction: A comprehensive review of clinical manifestations and interventions.

Tang X, Liu G, Zeng YJ

World journal of psychiatry 2025; (15(12)):110290 doi:10.5498/wjp.v15.i12.110290.

Non-ST-segment elevation acute coronary syndrome: understanding the full spectrum to guide management.

Savonitto S, Alpert JS, Thiele H, et al.

European heart journal 2025; doi:10.1093/eurheartj/ehaf958.

A narrative review of electrocardiogram manifestation of myocardial infarction with non-obstructive coronary arteries (MINOCA).

Raul A, Gupta S, Hung A, et al.

Journal of thoracic disease 2025; (17(12)):11420-11428 doi:10.21037/jtd-2025-1688.

A novel multimodal imaging approach for working diagnosis of acute myocardial infarction with non-obstructive coronary arteries: a promising diagnostic strategy.

Taverna G, Canton L, Zilio L, et al.

Frontiers in cardiovascular medicine 2025; (12()):1646418 doi:10.3389/fcvm.2025.1646418.

Discontinuation of Beta-Blocker Therapy after Myocardial Infarction.

Choi KH, Kang D, Kim W, et al.

The New England journal of medicine 2026; (394(13)):1302-1312 doi:10.1056/NEJMoa2601005.

Hematuria Management in Patients on Antiplatelet Medications After Acute Coronary Syndrome: A Review of the Current Evidence and Recommendations.

Loufopoulos I, Kapriniotis K, Fyntanidou B, et al.

Reviews in cardiovascular medicine 2026; (27(3)):46334 doi:10.31083/RCM46334.

Sex disparities in pre-hospital delay in patients with acute myocardial infarction: a systematic review and meta-analysis.

Hu D, Duan Y, Song J, Wei L

BMC cardiovascular disorders 2026; (26(1)).

Association of the Mediterranean Diet, Physical Activity and Related Lifestyle Factors on the Mortality and Major Adverse Cardiovascular Events in Patients with Coronary Heart Disease: A Systematic Review and Meta-Analysis.

Mo L, Qiu F, Liu Y, et al.

Nutrients 2026; (18(16)) doi:10.3390/nu18162589.